Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | tyrosyl-DNA phosphodiesterase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0039 | 0.0037 | 0.0118 | |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0303 | 0.1122 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0064 | 0.0237 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.0373 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0066 | 0.0373 | 0.0373 |
Mycobacterium leprae | Probable lipase LipE | 0.0039 | 0.0037 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0039 | 0.0037 | 0.5 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0039 | 0.0037 | 0.0137 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0249 | 0.2672 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.0548 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0066 | 0.0373 | 0.1274 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.008 | 0.0548 | 0.2028 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0303 | 0.1122 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.0037 | 0.0137 |
Brugia malayi | beta-lactamase | 0.0039 | 0.0037 | 0.0137 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.0373 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.0037 | 0.0037 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0039 | 0.0037 | 0.0037 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0066 | 0.0373 | 0.0373 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.008 | 0.0548 | 0.0548 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0037 | 0.0137 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.0548 | 1 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.008 | 0.0548 | 0.0548 |
Onchocerca volvulus | 0.0039 | 0.0037 | 0.0118 | |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0037 | 0.0137 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0303 | 0.1122 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0037 | 0.0137 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0037 | 0.0137 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0066 | 0.0373 | 0.0373 |
Wolbachia endosymbiont of Brugia malayi | extracellular metallopeptidase | 0.0607 | 0.7161 | 0.5 |
Loa Loa (eye worm) | beta-lactamase | 0.0039 | 0.0037 | 0.0137 |
Schistosoma mansoni | polycystin 1-related | 0.0053 | 0.0217 | 0.0217 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0037 | 0.0137 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.0037 | 0.0037 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.008 | 0.0548 | 1 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.008 | 0.0548 | 0.0548 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.0373 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0039 | 0.0037 | 0.0037 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.27 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0064 | 0.0064 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0066 | 0.0373 | 0.0373 |
Plasmodium vivax | hypothetical protein, conserved | 0.0039 | 0.0037 | 1 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0046 | 0.0127 | 0.0127 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.0037 | 0.0137 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0066 | 0.0373 | 1 |
Onchocerca volvulus | 0.0286 | 0.3136 | 1 | |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.0548 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0064 | 0.0237 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.3136 | 1 |
Onchocerca volvulus | 0.0039 | 0.0037 | 0.0118 | |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0039 | 0.0037 | 0.0137 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0066 | 0.0373 | 0.6573 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.27 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0037 | 0.0137 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0046 | 0.0127 | 0.0127 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.008 | 0.0548 | 0.5 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.008 | 0.0548 | 0.2028 |
Toxoplasma gondii | ABC1 family protein | 0.0039 | 0.0037 | 0.0991 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0303 | 0.1122 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AbsAC1000_uM (functional) | = 5.519 uM | PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552] | ChEMBL. | No reference |
AbsAC40_uM (functional) | 3.97 uM | PubChem BioAssay. In vivo-based yeast HTS counterscreen to detect compounds rescuing yeast growth/survival of Saccharomyces cerevisiae SKN7-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | > 94.089 uM | PubChem BioAssay. Counterscreen for inhibitors of T-cell receptor (TCR)-CD3 interaction: Fluorescence-based biochemical high throughput dose response assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled BSA probe. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 5.0119 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)] | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.